Pharmacology- Cholesterol Flashcards

1
Q

are lipids soluble in water

A

insoluble or sparing soluble in water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are lipids essential for

A

membrane biogenesis and membrane integrity, energy sources, precursors for hormones and signalling molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are two examples of non polar lipids

A

cholesterol esters and triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are non polar lipids transported within the blood

A

within lipoproteins (e.g. HDL and LDL (high/low density)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what ratio of HDL and LDL is cardiovascular disease associated with (atherosclerosis)

A

elevated LDL and decreased HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the causes of a high LDL to HDL ratio

A

diet and lifestyle (western), genetic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does the synthesis of all steroid hormones start with

A

cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe the structure of lipoproteins

A

7-1000 nM in diameter, hydrophobic core and hydrophilic core

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does the hydrophobic core of lipoproteins contain

A

esterified cholesterol and triglycerides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does the hydrophilic coat of lipoproteins contain

A

monolayer of amphipathic cholesterol, phospholipids and one/more apoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 4 major lipoproteins

A

HDL, LDL, VLDL (very low density), chylomicrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what apoproteins do HDL particles contain

A

apoA1 and apoA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what apoproteins do LDL particles contain

A

apoB-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what apoproteins do VLDL particles contain

A

apoB-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what apoproteins do chylomicrons particles contain

A

apoB-48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where do ApoB-containing lipoproteins deliver triglycerides to (2)

A

1- muscle for ATP biogenesis

2- adipocytes (fat cells) for storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe the exogenous pathway

A

Chylomicrons are formed in intestinal cells and transport dietary triglycerides

involves the absorption, distribution and delivery of lipids from diet to the periphery tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe the endogenous pathway

A

VLDL particles are formed in liver cells and transport triglycerides synthesised in the liver

involves lipid synthesis by liver and delivery to peripheral tissue via VLD lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe the life cycle of apoB-containing liposomes

A

1- assembly; apoB100 (liver) and apoB48 (intestine)

2- intravascular metabolism; (ivloves hydrolyses of triglyceride core)

3- receptor mediated clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

(assembly of chylomicrons)

what breaks down dietary fat first and where

A

lipases in the intestine (formed in the pancreas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

(assembly of chylomicrons)

what is dietary fat broken down into to enter the cells lining gut lumen (via diffusion)

A

monoglyceride and free fatty acid (long chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

(assembly of chylomicrons)

what happens when the monoglyceride and free fatty acid chain are within the cell

A

triglyceride synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

(assembly of chylomicrons)

how is cholesterol transported into the cell

A

via Niemann-Pick C1-like 1 protein

NPC1L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

(assembly of chylomicrons)

what happens to cholesterol once it is inside the cell

A

esterification to make cholesteryl ester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is an enterocyte

A

cell of the intestine lining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

(assembly of chylomicrons)

what does cholesteryl ester eventually form

A

apoB48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

(assembly of chylomicrons)

what is the apoB48 produced in enterocytes added to

A

triglyceride droplets within cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is lipidation

A

the addition of hydrophobic molecules to a protein or chemical compound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

(assembly of chylomicrons)

how what are the final stages of chylomicron formation

A

lipidation (assisted with MTP), and addition of cholesteryl ester and apoA1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

(assembly of chylomicrons)

how does the chylomicron exit the cell and where does it go

A

exits via exocytosis and enters the lymphatics where it is carried in lymph to systemic circulation (subclavian vein) via the thoracic duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

where are VLDL particles assembeled

A

in liner hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what are VLDL particles synthesised from

A

from free fatty acids from adipose tissue and de novo synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what is the role of MTP in the assembly of VLDL particles

A

MTP lipidates apoB100 forming nascent VLDL that coalesces with triglyceride droplets

34
Q

how are chylomicrons and VLDL particles activated (to deliver adipose and muscle tissue

A

the transfer of apoCII from HDL particles into the shell of VLDL and chylomicron particles

35
Q

what is the role of HDL

A

mops up excess cholesterol in the blood and carry it to the liver where it is secreted in bile

36
Q

what does the transfer of apoCII facilitate

A

facilitates binding of chylomicrons and VLDL particles to LPL

37
Q

what is LPL

A

Lipoprotein lipase (LPL) – lipolytic enzyme associated with the endothelium of capillaries in adipose and muscle tissue

38
Q

how does LPL act on VLDL and LPL

A

LPL hydrolyses core triglycerides to free fatty acids and glycerol which enter tissues

39
Q

what are chylomicron and VLDL remnants

A

Particles depleted of triglycerides (but still containing cholesteryl esters)

40
Q

what happens to apoCII after VLDL and chylomicrons dissociate from LPL

A

ApoCII is transferred to HDL particles in exchange for apoE. particles are now remnants

41
Q

what is apoE

A

a high affinity ligand for receptor mediated clearance

42
Q

where do the VLDL anf chylomicrons return to and what happens

A

return to liver and are further metabolised by hepatic lipase

43
Q

what are all apoB48 containing remnants and 50% of all apo100 containing remnants cleared by

A

receptor-mediated endocytosis into hepatocytes

44
Q

what happens to the remaining 50% of apoB100 containing lipoproteins not cleared by receptor mediated endocytosis

A

remnants loose further triglyceride through hepatic lipase, become smaller and enriched in cholesteryl ester and via intermediate density lipoproteins (IDL) become LDL particles lacking apoE and retaining solely apoB100

45
Q

what is clearance of LDL dependant on

A

LDL receptor expression by the liver and other tissues (liver most important)

46
Q

how does cellular uptake of LDL occur via

A

via receptor-mediated endocytosis

47
Q

what is endocytosis

A

process of capturing a substance or particle from outside the cell by engulfing it with the cell membrane, and bringing it into the cell.

48
Q

whats a lysosome

A

little enzyme package (organelle)

49
Q

describe the release of cholesterol within the cell

A

released from cholesteryl ester (CE) at the lysosome via hydrolysis

50
Q

what does released cholesterol cause

A

inhibition of HMG-CoA reductase which is the rate limiting enzyme in de novo cholesterol synthesis

down regulation of LDL receptor expression

storage of cholesterol as cholesterol ester

51
Q

what do statins do

A

block the synthesis of cholesterol in the liver cell and thus increase surface expression of LDL receptors, therefore LDL cells more readily cleared form the plasma

52
Q

what happens to LDL after it is taken into the endothelium of the artery from the blood

A

LDL is oxidised to atherogenic oxidised (OXLDL)

53
Q

what initiates atherosclerosis

A

dysfunction and injury of the lining of blood vessels

54
Q

describe the formation of fatty streaks in endothelium

A

monocytes migrate to across the endothelium into the intima where they become macrophages and uptake OXLDL and convert them to cholesterol-laden foam cells that form a fatty streak

55
Q

what is a fatty streak a sign of

A

early event in atherosclerosis

56
Q

describe the formation of an atheromatous plaque

A

release of inflammatory substances from various cell types causing division and proliferation (rapid increase in number) of smooth muscle cells in the intima and the deposition of collagen

57
Q

describe the composition of an atheromatous plaque

A

a lipid core (product of dead foam cells) and a fibrous cap (smooth muscle cells and connective tissue)

58
Q

why is HDL the good cholesterol

A

has a key role in removing excess cholesterol from cells by transporting it in plasma to the liver (reverse cholesterol transport)

59
Q

where is HDL mainly formed

A

in the liver

60
Q

in the plasma what mediates the transfer of cholesteryl esters indirectly returning cholesterol to the liver

A

cholesterol ester transfer protein (CETP)

61
Q

what causes primary dyslipidaemia

A

combination of diet and genetic factors

62
Q

what causes secondary dyslipidaemia

A

is a consequence of other diseases

63
Q

what is dyslipidaemia

A

abnormal amount of lipids

64
Q

what is the drugs of choice to reduce LDL

A

statins

65
Q

give 2 example of statins

A

simvastatin and atorvastatin

66
Q

what do statins act on and how

A

Act as competitive inhibitors of HMG-CoA reductase (limiting step in cholesterol synthesis in hepatocytes

67
Q

how do statins reduce LDL levels

A

as decrease in hepatocyte cholesterol synthesis causes a compensatory increase in LDL receptor expression and enhanced clearance of LDL

68
Q

what are other beneficial effects of statins

A

Decreased inflammation

Reversal of endothelial dysfunction

Decreased thrombosis

Stabilization of atherosclerotic plaques

69
Q

how are statins administered

A

orally at night

70
Q

what do fibrates do

A

caused pronounced decrease in triglycerides and modest decreases in LDL and HDL

71
Q

what are two examples of fibrates

A

bezafibrate and gemfibrozil

72
Q

what are fibrates used to treat

A

very high triglyceride levels

73
Q

how do fibrates act

A

as agonists of a nuclear receptor (PPARalpha) to enhance the transcription of several genes, including that encoding LPL

74
Q

what adverse effect can statins and fibrates cause

A

myositis

75
Q

give three examples of drugs that inhibit cholesterol absorption

A

colestyramine, colestipol, colsevelam

76
Q

describe how bile acid binding resins work to inhibit cholesterol absorption

A

) cause the excretion of bile salts resulting in more cholesterol to be converted to bile salts by interrupting enterohepatic recycling

77
Q

what do binding resins cause

A

decreased absorption of triglycerides

increased LDL receptor function

78
Q

what is ezetimibe

A

acts to inhibit NPC1L1 transport protein in enterocytes of the duodenum, reducing the absorption of cholesterol

79
Q

what types of cholesterol does ezetimibe affect

A

decreases LDL but doesn’t really affect HDL

80
Q

describe the administration of ezetimibe

A

used in combo with statins when statins not enough. Not in breastfeeding females